ArticleFrontiers in public health2026
Experiences of psychosomatic symptoms and self-management strategies among patients with advanced lung cancer undergoing chemotherapy: a qualitative study based on symptom management theory.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer is among the malignancies with the heaviest disease burden worldwide. Patients with advanced lung cancer face substantial physical and psychological challenges during chemotherapy-based treatment. Psychosomatic symptoms are important factors influencing patients' quality of life and treatment adherence. However, although the incidence of psychosomatic symptoms in patients with advanced lung cancer undergoing chemotherapy is relatively high, their identification rates remain low. Objectives: This study guided by symptom management theory, and aims to explore from the patients' perspective, the psychosomatic symptom experiences, management strategies, outcomes and influencing factors among individuals undergoing chemotherapy for advanced lung cancer. Methods: A descriptive qualitative research design was employed. Using purposive sampling, semi-structured interviews were conducted with 17 patients undergoing chemotherapy for advanced lung cancer in the Department of Medical Oncology at a tertiary Grade A hospital in Yantai City between September and December 2025. Data were analyzed using directed content analysis, and themes were extracted accordingly. NVivo 15.0 software was utilized for data management and coding. Results: After organizing, analyzing, and synthesizing the interview data, four themes and twelve categories emerged from the qualitative data: symptom experiences(complex and diverse physical symptom experiences, multidimensional interaction of psychological symptom experiences, limited social roles and functional capacity); symptom management strategies(positive approach to challenges, negative responses to symptoms); symptom outcomes(persistent psychological burden and disease-related uncertainty, reconstructing psychosomatic adaptation and self-management abilities, seeking professional medical assistance and psychological support); influencing factors(individual factors, disease and treatment factors, family and social environmental factors, cultural factors). Conclusion: Based on symptom management theory, this study found that patients with advanced lung cancer undergoing chemotherapy experience multidimensional and complex psychosomatic symptoms, display varying coping strategies and have diverse symptom outcomes. Their symptom management is influenced by multiple factors, including individual characteristics, environmental conditions, and disease-related aspects. Healthcare professionals should closely attend to patients' psychosomatic experiences, guide them in adopting positive coping strategies, facilitate accurate disease understanding, and promote psychological well-being. Simultaneously, identifying the relevant factors affecting symptom management and providing targeted health education can help improve long-term symptom outcomes and reduce the overall disease burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.